Emirates News Agency on MSN

UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
Edex Live on MSN

UAE approves gene replacement therapy for wider SMA age group

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...

UAE approves Itvisma gene therapy: A leap in medical innovation

The Emirates Drug Establishment (EDE) has formally authorised Itvisma ( onasemnogene abeparvovec ), marking a new chapter for gene therapy treatment of spinal muscular atrophy (SMA) for both adults ...

Misunderstood illness leaves millions exhausted, with most cases undiagnosed

What causes chronic fatigue syndrome? From viral infections to immune disorders, discover the triggers and symptoms behind ...

The Diagnostic Challenge of Chronic Fatigue Syndrome

ME/CFS is a neurological condition characterized by malaise. Diagnosis requires ruling out other systemic illnesses.
The National on MSN

UAE approves Novartis gene therapy treatment for spinal muscular atrophy

Itvisma, developed by Swiss pharmaceutical company Novartis, works to replace the defective SMN1 gene responsible for the ...